Long-term Outcomes of Kidney Transplantation in Patients With High Levels of Preformed DSA

Abstract

These results suggest that DSA-sensitized patients with high MFI levels can receive transplantation across the HLA-barrier, with the use of an intensified posttransplant immunosuppressive therapy starting at day 0 combined with close clinical, immunologic, and histologic monitoring.